Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Zimmer Biomet Holdings, Inc.

NYSE

Market Cap.

23.95B

Avg. Volume

1.24M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Zimmer Biomet Holdings, Inc.!

Still processing it, give me a bit more time...

Zimmer Biomet Holdings, Inc. News

Zimmer Biomet Holdings, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
zimmerbiomet.com

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings, Inc. Earnings & Revenue

Zimmer Biomet Holdings, Inc. Financials

Table Compare

Compare ZBH metrics with:

   

Earnings & Growth

ZBH

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZBH

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZBH

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZBH

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Zimmer Biomet Holdings, Inc. Income

Zimmer Biomet Holdings, Inc. Balance Sheet

Zimmer Biomet Holdings, Inc. Cash Flow

Zimmer Biomet Holdings, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Zimmer Biomet Holdings, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.9600

Payment DateDividendFrequency
2024-07-310.24Quarterly
2024-04-300.24Quarterly
2023-07-310.24Quarterly
2023-04-280.24Quarterly
2023-01-310.24Quarterly

Historical Market Cap

Shares Outstanding

Zimmer Biomet Holdings, Inc. Executives

NameRole
Mr. Ivan TornosChief Operating Officer, President, Chief Executive Officer & Director
Mr. Suketu P. UpadhyayChief Financial Officer and Executive Vice President of Finance, Operations & Supply Chain
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & Africa
Mr. Sang YiPresident of Asia Pacific
Mr. Chad F. PhippsSenior Vice President, General Counsel & Secretary
NameRoleGenderDate of BirthPay
Mr. Ivan TornosChief Operating Officer, President, Chief Executive Officer & DirectorMale19752.72M
Mr. Suketu P. UpadhyayChief Financial Officer and Executive Vice President of Finance, Operations & Supply ChainMale19692.01M
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & AfricaMale19701.47M
Mr. Sang YiPresident of Asia PacificMale19621.38M
Mr. Chad F. PhippsSenior Vice President, General Counsel & SecretaryMale19721.32M

Zimmer Biomet Holdings, Inc. Insider Trades

Date10 May
NameShapiro Louis
RoleDirector
TransactionAcquired
TypeA-Award
Shares616.726
Date10 May
NameShapiro Louis
RoleDirector
TransactionAcquired
TypeA-Award
Shares1068.991
Date10 May
NameMICHELSON MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares0
Date10 May
NameMICHELSON MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares0
Date10 May
NameKolli Sreelakshmi
RoleDirector
TransactionAcquired
TypeA-Award
Shares616.726
DateNameRoleTransactionTypeShares
10 MayShapiro LouisDirectorAcquiredA-Award616.726
10 MayShapiro LouisDirectorAcquiredA-Award1068.991
10 MayMICHELSON MICHAEL WDirectorAcquiredA-Award0
10 MayMICHELSON MICHAEL WDirectorAcquiredA-Award0
10 MayKolli SreelakshmiDirectorAcquiredA-Award616.726

Discover More

Streamlined Academy

Zimmer Biomet Holdings, Inc.

NYSE

Market Cap.

23.95B

Avg. Volume

1.24M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Zimmer Biomet Holdings, Inc. News

Zimmer Biomet Holdings, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Zimmer Biomet Holdings, Inc. Earnings & Revenue

Zimmer Biomet Holdings, Inc. Income

Zimmer Biomet Holdings, Inc. Balance Sheet

Zimmer Biomet Holdings, Inc. Cash Flow

Zimmer Biomet Holdings, Inc. Financials Over Time

Zimmer Biomet Holdings, Inc. Executives

NameRole
Mr. Ivan TornosChief Operating Officer, President, Chief Executive Officer & Director
Mr. Suketu P. UpadhyayChief Financial Officer and Executive Vice President of Finance, Operations & Supply Chain
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & Africa
Mr. Sang YiPresident of Asia Pacific
Mr. Chad F. PhippsSenior Vice President, General Counsel & Secretary
NameRoleGenderDate of BirthPay
Mr. Ivan TornosChief Operating Officer, President, Chief Executive Officer & DirectorMale19752.72M
Mr. Suketu P. UpadhyayChief Financial Officer and Executive Vice President of Finance, Operations & Supply ChainMale19692.01M
Mr. Wilfred van ZuilenGroup President of Europe, Middle East & AfricaMale19701.47M
Mr. Sang YiPresident of Asia PacificMale19621.38M
Mr. Chad F. PhippsSenior Vice President, General Counsel & SecretaryMale19721.32M

Zimmer Biomet Holdings, Inc. Insider Trades

Date10 May
NameShapiro Louis
RoleDirector
TransactionAcquired
TypeA-Award
Shares616.726
Date10 May
NameShapiro Louis
RoleDirector
TransactionAcquired
TypeA-Award
Shares1068.991
Date10 May
NameMICHELSON MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares0
Date10 May
NameMICHELSON MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares0
Date10 May
NameKolli Sreelakshmi
RoleDirector
TransactionAcquired
TypeA-Award
Shares616.726
DateNameRoleTransactionTypeShares
10 MayShapiro LouisDirectorAcquiredA-Award616.726
10 MayShapiro LouisDirectorAcquiredA-Award1068.991
10 MayMICHELSON MICHAEL WDirectorAcquiredA-Award0
10 MayMICHELSON MICHAEL WDirectorAcquiredA-Award0
10 MayKolli SreelakshmiDirectorAcquiredA-Award616.726

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
zimmerbiomet.com

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Zimmer Biomet Holdings, Inc.!

Still processing it, give me a bit more time...

Zimmer Biomet Holdings, Inc. Financials

Table Compare

Compare ZBH metrics with:

   

Earnings & Growth

ZBH

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZBH

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZBH

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZBH

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Zimmer Biomet Holdings, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.9600

Payment DateDividendFrequency
2024-07-310.24Quarterly
2024-04-300.24Quarterly
2023-07-310.24Quarterly
2023-04-280.24Quarterly
2023-01-310.24Quarterly

Zimmer Biomet Holdings, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More